Progenics Pharmaceuticals, Inc.

Progenics Pharmaceuticals, Inc. (United States) has no DMF, CEP or site registration linked in our records. 8 FDA enforcement records are linked to it.

Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records

Cite as: PharmaTek, “Progenics Pharmaceuticals, Inc.: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/progenics-pharmaceuticals-inc

Overview

Progenics Pharmaceuticals, Inc. is an oncology company focused on the development of innovative medicines and artificial intelligence to find, fight and follow cancer. It is a subsidiary of Lantheus Holdings, Inc.

Therapeutic areas

OncologyRadiopharmaceuticals

FDA compliance signals

8 FDA enforcement records linked to this company.

  • 4832020-03-20

    Investigations of discrepancies, failures

  • 4832020-03-20

    Incoming material area

  • 4832020-03-20

    Aseptic Processing Area

  • 4832020-03-20

    Review of representative number of batches

  • 4832020-03-20

    Procedures for sterile drug products

  • 4832020-03-20

    Computer control of master formula records

  • 4832020-03-20

    Adequate space lacking to prevent mix-ups and contamination

  • 4832020-03-20

    Procedures not in writing, fully followed

For suppliers

Is this Progenics Pharmaceuticals, Inc.?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.

Need suppliers found and checked?

The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.